PMID- 28088050 OWN - NLM STAT- MEDLINE DCOM- 20170816 LR - 20181202 IS - 1525-5069 (Electronic) IS - 1525-5050 (Linking) VI - 67 DP - 2017 Feb TI - Pharmacists' knowledge of issues in pharmacotherapy of epilepsy using antiepileptic drugs: A cross-sectional study in Palestinian pharmacy practice. PG - 39-44 LID - S1525-5050(16)30602-3 [pii] LID - 10.1016/j.yebeh.2016.11.027 [doi] AB - OBJECTIVE: Antiepileptic drugs (AEDs) are mainstay in controlling epileptic seizures. As experts in medications, pharmacists should be able to ensure accuracy of dosing regimens, explain adverse effects, and screen for and alert people with epilepsy (PWE) and their physicians to possible drug-drug interactions (DDIs). The aim of this study was to evaluate pharmacists' knowledge of issues in pharmacotherapy of epilepsy using AEDs. METHODS: This was a cross-sectional observational study conducted in the Palestinian pharmacy practice. A 10-item case-based questionnaire was used to determine actions taken by pharmacists in theoretical situations in pharmacotherapy of epilepsy. Demographic and practice details of the study participants were also collected. Scores were calculated as percentage of correct answers for each participant. RESULTS: The number of participants was 394. The majority (approximately 75%) identified themselves as community pharmacists. The median score was 33.4% with an IQR of 33.3. Pharmacists who received training on epilepsy and AEDs during their pharmacy degree program were 4.78-fold (95% C.I. of 1.82-12.60) more likely to score >/=50% in the test than those who did not receive training on epilepsy and AEDs. Despite gaps in knowledge, pharmacists tended to perform the necessary action in cases of adverse effects and aggravated seizures associated with AEDs. CONCLUSION: Pharmacists can play a crucial role in providing essential information on AEDs to patients and prescribers. There are many knowledge gaps that need to be filled. Specifically designed pedagogic and/or training interventions might be helpful in filling these gaps. CI - Copyright (c) 2016 Elsevier Inc. All rights reserved. FAU - Shawahna, Ramzi AU - Shawahna R AD - Department of Physiology, Pharmacology and Toxicology, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; An-Najah BioSciences Unit, Centre for Poisons Control, Chemical and Biological Analyses, An-Najah National University, Nablus, Palestine; Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. Electronic address: ramzi_shawahna@hotmail.com. FAU - Atrash, Ahlam AU - Atrash A AD - Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. FAU - Jebril, Aman AU - Jebril A AD - Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. FAU - Khalaf, Areen AU - Khalaf A AD - Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. FAU - Shaheen, Eman AU - Shaheen E AD - Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. FAU - Tahboosh, Hala AU - Tahboosh H AD - Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. LA - eng PT - Journal Article PT - Observational Study DEP - 20170112 PL - United States TA - Epilepsy Behav JT - Epilepsy & behavior : E&B JID - 100892858 RN - 0 (Anticonvulsants) SB - IM MH - Adult MH - Anticonvulsants/*therapeutic use MH - *Arabs MH - Cross-Sectional Studies MH - Drug Interactions MH - Epilepsy/*drug therapy/epidemiology MH - Female MH - *Health Knowledge, Attitudes, Practice MH - Humans MH - Male MH - Middle Aged MH - Pharmacies/*standards MH - Pharmacists/*standards MH - Professional Role MH - Surveys and Questionnaires OTO - NOTNLM OT - Antiepileptic drugs OT - Epilepsy OT - Knowledge OT - Palestine OT - People with epilepsy OT - Pharmacists EDAT- 2017/01/15 06:00 MHDA- 2017/08/17 06:00 CRDT- 2017/01/15 06:00 PHST- 2016/10/21 00:00 [received] PHST- 2016/11/16 00:00 [revised] PHST- 2016/11/17 00:00 [accepted] PHST- 2017/01/15 06:00 [pubmed] PHST- 2017/08/17 06:00 [medline] PHST- 2017/01/15 06:00 [entrez] AID - S1525-5050(16)30602-3 [pii] AID - 10.1016/j.yebeh.2016.11.027 [doi] PST - ppublish SO - Epilepsy Behav. 2017 Feb;67:39-44. doi: 10.1016/j.yebeh.2016.11.027. Epub 2017 Jan 12.